# Taiwan’s Smart Healthcare Value Chain: AI Innovation from R&D to Industry Deployment

**Authors:** Tzu-Min Lin, Hui-Wen Yang, Ching-Cheng Han, Chih-Sheng Lin

PMC · DOI: 10.3390/healthcare14010023 · Healthcare · 2025-12-21

## TL;DR

Taiwan is leveraging AI and digital healthcare to improve medical quality and efficiency, supported by government policies and strong ICT industry involvement.

## Contribution

The paper highlights Taiwan's unique integration of AI, healthcare policy, and ICT industry collaboration in smart healthcare development.

## Key findings

- Taiwan's National Health Insurance system and ICT strengths support digital healthcare innovation.
- Government policies and regulatory reforms are accelerating smart healthcare advancements.
- Leading ICT companies are actively participating in developing Taiwan's smart healthcare ecosystem.

## Abstract

Taiwan’s strategic focus in digital healthcare has been officially integrated into national industrial policy and identified as a crucial application area for artificial intelligence (AI) and next-generation communication technologies. As the healthcare sector undergoes rapid digital transformation, digital healthcare technologies have emerged as essential tools for improving medical quality and efficiency. Leveraging the extensive coverage of its National Health Insurance (NHI) system and its strengths in Information and Communications Technology (ICT), Taiwan also benefits from the robust research capacity of universities and hospitals. Government-driven regulatory reforms and infrastructure initiatives are further accelerating the advancement of the NHI MediCloud system and the broader digital healthcare ecosystem. This article provides a comprehensive overview of smart healthcare development, highlighting government policy support and the R&D capabilities of universities, research institutes, and hospitals. It also examines the ICT industry’s participation in the development of smart healthcare ecosystems, such as Foxconn, Quanta, Acer, ASUS, Wistron, Qisda, etc. With strong data assets, technological expertise, and policy backing, Taiwan demonstrates significant potential in both AI innovation and smart healthcare applications, steadily positioning itself as a key player in the global healthcare market.

## Full-text entities

- **Diseases:** kidney disease (MESH:D007674), SaMD (MESH:D009471), chronic diseases (MESH:D002908), brain tumor (MESH:D001932), thyroid cancer (MESH:D013964), cardiovascular disorders (MESH:D002318), COVID-19 (MESH:D000086382), DR (MESH:D003930), solitary pulmonary nodules (MESH:D003074), AI (MESH:C538142), acute kidney injury (MESH:D058186), stroke (MESH:D020521), injury to (MESH:D014947), sarcopenia (MESH:D055948), AMD (MESH:D006009), pancreatic cancer (MESH:D010190), lung cancer (MESH:D008175), diabetes (MESH:D003920), cancer (MESH:D009369)
- **Chemicals:** TFDA (-)
- **Species:** Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12786189/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12786189/full.md

## References

121 references — full list in the complete paper: https://tomesphere.com/paper/PMC12786189/full.md

---
Source: https://tomesphere.com/paper/PMC12786189